The increasing public profile of Lyme disease, amplified by celebrity diagnoses and media coverage, is leading to a rise in patients self-diagnosing with the condition, according to Dr. Max Pemberton. He expresses concern that the distinction between actual Lyme disease and what is termed 'Chronic Lyme' is often blurred, potentially leading to misdiagnosis and ineffective treatments.
Lyme disease is a bacterial infection transmitted through tick bites, primarily caused by the bacterium Borrelia. Early symptoms can include a rash, often resembling a bullseye, though this is not present in all cases. Flu-like symptoms such as aches and tiredness may follow. If left untreated, Lyme disease can progress to more severe issues, including facial drooping, heart inflammation, and joint problems.
Dr. Pemberton notes that Lyme disease is treatable with a short course of antibiotics, typically doxycycline, when caught early. Recorded cases in England have shown an increase, with 1,170 confirmed cases in the past year, up from 959 the year before. This rise is attributed partly to warmer weather providing ticks more time to feed and increased public awareness leading to more testing, rather than an epidemic.
However, the term 'Lyme' is increasingly being used to describe a broader range of persistent, vague symptoms, referred to as 'Chronic Lyme Disease.' These can include headaches, exhaustion, muscle aches, and cognitive difficulties, which some patients believe are caused by a lingering Borrelia infection. Dr. Pemberton highlights that in many 'Chronic Lyme' cases, there is no clear history of initial infection, and standard diagnostic tests return negative results.
Some patients who receive negative test results become convinced the tests are flawed and may seek unregulated tests from overseas laboratories. Dr. Pemberton points to a 2007 study in the New England Journal of Medicine that found no convincing evidence linking these persistent symptoms to Borrelia. Subsequent studies have also failed to find evidence of lingering infection causing these symptoms.
Concerns are also raised about treatments advocated by some patient groups and doctors, such as long courses of antibiotics. Dr. Pemberton states that controlled trials have shown these treatments are no more effective than a placebo and carry significant risks. He also references a recent pilot study involving psilocybin for persistent Lyme symptoms, cautioning that its small scale and lack of a control group make its findings inconclusive.
Dr. Pemberton stresses that while the distress experienced by patients with these persistent symptoms is real and they deserve serious attention, accepting a diagnosis without supporting evidence is not beneficial. He argues that if symptoms are not caused by an infection, more antibiotics will not help. The most compassionate approach, he believes, is to honestly assess the situation and consider all potential causes, which may not be related to a tick-borne illness.